Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis (2017)

First Author: Smith W
Attributed to:  The T6SS toxins are powerful weapons for Pseudomonas' antibacterial strategy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/femsle/fnx121

PubMed Identifier: 28854668

Publication URI: http://europepmc.org/abstract/MED/28854668

Type: Journal Article/Review

Parent Publication: FEMS Microbiology Letters

Issue: 14

ISSN: 0378-1097